Showing results (71-80 of 102) with videos related to
Sort By:
Pageof 11
Blood|April 1, 1984
Blastic transformation of essential thrombocythemia: dual expression of myelomonoblastic/megakaryoblastic phenotypesD Frei-Lahr, J C Barton, R Hoffman, et al.The American Journal of Pathology|December 1, 1982
Ultrastructural localization of lactoferrin and iron-binding protein in human neutrophils and rabbit heterophilsR T Parmley, M Takagi, J C Barton, et al.American Journal of Hematology|September 21, 2000
Abnormalities of flavin monooxygenase as an etiology for sideroblastic anemiaM Barber, M E Conrad, J N Umbreit, et al.Cancer Research|September 15, 1987
Cytochemistry and ultrastructural morphometry of cultured HL60 myeloid leukemia cellsR T Parmley, D T Akin, J C Barton, et al.Ethnicity & Disease|January 5, 2002
HFE mutations in African-American women with non-insulin-dependent diabetes mellitusR T Acton, J C Barton, D S Bell, et al.Acta Haematologica|January 1, 1992
Neutrophil function in chronic neutrophilic leukemia: defective respiratory burst in response to phorbol estersS S Kaplan, R L Berkow, R A Joyce, et al.Journal of Immunological Methods|April 6, 1988
Assessment of total immunoreactive lactoferrin in hematopoietic cells using flow cytometryT W Butler, L W Heck, W J Huster, et al.Blood Cells, Molecules & Diseases|May 19, 2001
Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overloadE H Barton, P A West, C A Rivers, et al.The Journal of Computed Tomography|July 1, 1987
Malignant hemangiopericytoma: computed tomography and magnetic resonance imagingM S Shin, R E Koehler, R J Stanley, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapyM S Aapro, S M Grunberg, G M Manikhas, et al.Pageof 11